GregoryJRielyMDPhD

PubMed

• Single-Cell Sequencing Illuminates Thymic Development: An Updated Framework for Understanding Thymic Epithelial Tumors.
  Christopher S Nabel, Abner Louissaint Jr, Jeanne B Ackman, Yin P Hung, Gregory J Riely> ;The Oncologist. 2024 Mar 23
• Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-Cancer Clinicogenomic Data Set.
  Kenneth L Kehl, Jessica A Lavery, Samantha Brown, Hannah Fuchs, Gregory Riely, Deborah Schrag, Ashley Newcomb, Chelsea Nichols, Christine M Micheel, Philippe L Bedard,...> ;JCO Precision Oncology. 2024 Mar 1
• Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer Registry.
  Enrique Sanz-Garcia, Samantha Brown, Jessica A Lavery, Jessica Weiss, Hannah E Fuchs, Ashley Newcomb, Asha Postle, Jeremy L Warner, Michele L LeNoue-Newton, Shawn M Sw...> ;Cancer Research Communications. 2024 Feb 20
• A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.
  Riely, G., Smit, E., Ahn, M., Felip, E., Ramalingam, S., Tsao, A., Johnson, M., Gelsomino, F., Esper, R., Nadal, E., Offin, M., Provencio, M., Clarke, J., Hussein, M.,...> ;Future Oncology. 2024 Feb 15
• Intracranial Outcomes of De Novo Brain Metastases Treated With Osimertinib Alone in Patients With Newly Diagnosed EGFR-Mutant NSCLC.
  Reiner, A., Ilica, A., Miao, E., Panageas, K., Imber, B., Sehgal, R., Saganty, R., Li, B., Riely, G., Yu, H., Young, R., Pike, L., Moss, N.> ;JTO Clinical and Research Reports. 2023 Dec 1
• Effects of KRAS Genetic Interactions on Outcomes in Cancers of the Lung, Pancreas, and Colorectum.
  Isabella N Grabski, John V Heymach, Kenneth L Kehl, Scott Kopetz, Ken S Lau, Gregory J Riely, Deborah Schrag, Rona Yaeger, Rafael A Irizarry, Kevin M Haigis> ;Cancer Epidemiology, Biomarkers & Prevention. 2024 Jan 9
• MIG6 Mediates Adaptive and Acquired Resistance to ALK/ROS1 Fusion Kinase Inhibition through EGFR Bypass Signaling.
  Nan Chen, Logan C Tyler, Anh T Le, Eric A Welsh, Bin Fang, Andrew Elliott, Kurtis D Davies, Thomas Danhorn, Gregory J Riely, Marc Ladanyi, Eric B Haura, Doebele, R.> ;Molecular Cancer Therapeutics. 2024 Jan 3
• 23 citations
  Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal.
  Ino de Bruijn, Ritika Kundra, Brooke Mastrogiacomo, Thinh Ngoc Tran, Luke Sikina, Tali Mazor, Xiang Li, Angelica Ochoa, Gaofei Zhao, Bryan Lai, Adam Abeshouse, Diana B...> ;Cancer Research. 2023 Dec 1
• Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
  Chirieac, L. R., David S Ettinger, Douglas E Wood, James Stevenson, Dara L Aisner, Wallace Akerley, Jessica R Bauman, Ankit Bharat, Debora S Bruno, Joe Y Chang, Lucian...> ;Journal of the National Comprehensive Cancer Network. 2023 Sep 1
• 2 citations
  Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer.
  Arielle Elkrief, Biagio Riccuiti, Joao V Alessi, Teng Fei, Hannah L Kalvin, Jacklynn V Egger, Hira Rizvi, Rohit Thummalapalli, Guiseppe Lamberti, Andrew Plodkowski, Ma...> ;The Oncologist. 2023 Nov 2
• Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced- or-Rearranged NSCLC: A Brief Report.
  Rohit Thummalapalli, Noura J Choudhury, Fiona Ehrich, Tyler Beardslee, Danielle Brazel, Shannon S Zhang, Shelby Merchant, Monica F Chen, Glenn Heller, Suresh S Ramalin...> ;JTO Clinical and Research Reports. 2023 Aug 1
• 3 citations
  Clinical and Molecular Features of Long-term Response to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer.
  Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, Daniel Muldoon, Hira Rizvi, Arielle Elkrief, Jia Luo, Joao V Alessi, Federica Pecci, Giuseppe Lamberti, Ale...> ;Clinical Cancer Research. 2023 Nov 1
• 2 citations
  Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.2.
  Dwight H Owen, Navneet Singh, Nofisat Ismaila, Gregory Masters, Gregory J Riely, Andrew G Robinson, Bryan J Schneider, Ishmael A Jaiyesimi> ;Journal of Clinical Oncology. 2023 Aug 20
• 1 citations
  Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study.
  Arielle Elkrief, Joao M Victor Alessi, Biagio Ricciuti, Samantha Brown, Hira Rizvi, Isabel R Preeshagul, Xinan Wang, Federica Pecci, Alessandro Di Federico, Giuseppe L...> ;Journal for Immunotherapy of Cancer. 2023 Jul 1
• 2 citations
  Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non-Small Cell Lung Cancer Patients.
  Cloud P Paweletz, Grace A Heavey, Yanan Kuang, Emily Durlacher, Thian Kheoh, Richard C Chao, Alexander I Spira, Konstantinos Leventakos, Melissa L Johnson, Sai-Hong Ig...> ;Clinical Cancer Research. 2023 Aug 15
• 6 citations
  Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With-Mutant Metastatic Non-Small-Cell Lung Cancer.
  Gregory J Riely, Egbert F Smit, Myung-Ju Ahn, Enriqueta Felip, Suresh S Ramalingam, Anne Tsao, Melissa Johnson, Francesco Gelsomino, Raymond Esper, Ernest Nadal, Micha...> ;Journal of Clinical Oncology. 2023 Jul 20
• 6 citations
  Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced-Mutant Non-Small Cell Lung Cancer.
  Rohit Thummalapalli, Ezra Bernstein, Benjamin Herzberg, Bob T Li, Afsheen Iqbal, Isabel Preeshagul, Fernando C Santini, Juliana Eng, Marc Ladanyi, Soo-Ryum Yang, Rongl...> ;JCO Precision Oncology. 2023 Jun 1
• 1 citations
  The GENIE BPC NSCLC Cohort: A Real-World Repository Integrating Standardized Clinical and Genomic Data for 1,846 Patients with Non-Small Cell Lung Cancer.
  Noura J Choudhury, Jessica A Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc Tran, Hira Rizvi, Kathryn C Arbour, Karissa Whiting, Ronglai Shen, Matthew H...> ;Clinical Cancer Research. 2023 Sep 1
• 3 citations
  Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification.
  Arielle Elkrief, Igor Odintsov, Vladimir Markov, Rebecca Caeser, Pawel Sobczuk, Sam E Tischfield, Umesh Bhanot, Chad M Vanderbilt, Emily H Cheng, Alexander Drilon, Gre...> ;Journal of Thoracic Oncology. 2023 Sep 1
• 14 citations
  Genomic mapping of metastatic organotropism in lung adenocarcinoma.
  Harry B Lengel, Brooke Mastrogiacomo, James G Connolly, Kay See Tan, Yuan Liu, Cameron N Fick, Elizabeth G Dunne, Di He, Manendra B Lankadasari, Baby Anusha Satravada,...> ;Cancer Cell. 2023 May 8
• 68 citations
  NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023.
  David S Ettinger, Douglas E Wood, Dara L Aisner, Wallace Akerley, Jessica R Bauman, Ankit Bharat, Debora S Bruno, Joe Y Chang, Lucian R Chirieac, Malcolm DeCamp, Thoma...> ;Journal of the National Comprehensive Cancer Network. 2023 Apr 1
• 3 citations
  Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis.
  Andreas Rimner, Zachary R Moore, Stephanie Lobaugh, Alexander Geyer, Daphna Y Gelblum, Raja-Elie E Abdulnour, Annemarie F Shepherd, Narek Shaverdian, Abraham J Wu, Joh...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Aug 1
• 2 citations
  Conventional and radiomic features to predict pathology in the preoperative assessment of anterior mediastinal masses.
  Maria Mayoral, Andrew M Pagano, Jose Arimateia Batista Araujo-Filho, Junting Zheng, Rocio Perez-Johnston, Kay See Tan, Peter Gibbs, Annemarie Fernandes Shepherd, Andre...> ;Lung Cancer. 2023 Apr 1
• Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas.
  Arielle Elkrief, Alex Makhnin, Khadeja A Moses, Linda S Ahn, Isabel R Preeshagul, Afsheen N Iqbal, Sara A Hayes, Andrew J Plodkowski, Paul K Paik, Marc Ladanyi, Mark G...> ;Clinical Cancer Research. 2023 Apr 14
• 20 citations
  Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
  Vikas, P., Bakouny, Z., Labaki, C., Grover, P., Awosika, J., Gulati, S., Hsu, C., Alimohamed, S., Bashir, B., Berg, S., Bilen, M., Bowles, D., Castellano, C., Desai, A...> ;JAMA Oncology. 2023 Jan 1
• Join now to see all

Journal Articles

• Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients with Metastatic EGFR-Mutant Lung Cancers  
  Helena A Yu, Adam J Schoenfeld, Jamie E Chaft, Gregory J Riely, JAMA Oncology
• PD-L1 Expression, Tumor Mutational Burden, and Response to Immunotherapy in Patients with MET Exon 14 Altered Lung Cancers  
  G J Riely, J Dienstag, C Mrad, J K Sabari, M G Kris, K C Arbour, D F Halpenny, N Rekhtman, R Chen, A J Plodkowski, P K Paik, B T Li, I Bergagnini, M D Offin, C M Rudin..., Annals of Oncology
• YES1 Amplification Is a Mechanism of Acquired Resistance to EGFR Inhibitors Identified by Transposon Mutagenesis and Clinical Genomics  
  Emmet J Jordan, Helena A Yu, Yelena Y Janjigian, Mark G Kris, Paul K Paik, Jamie E Chaft, Lu Wang, Gregory J Riely, Proceedings of the National Academy of Sciences

Lectures

• Real-world utilization of EGFR TKI therapies and treatment outcomes in patients with advanced EGFR-sensitizing mutation-positive NSCLC. 
  2019 ASCO Annual Meeting - 6/1/2019
• American Society for Radiation Oncology(ASTRO): 20th Chicago Multidisciplinary Symposium inThoracic Oncology 
  American Society for Radiation Oncology, Chicago, Illinois - 9/6/2012
• Treating Stage I to III Non-Small-Cell Lung Cancer With Limited Evidence 
  2013 International Conference, Philadelphia, Pennsylvania, USA
• Treating Stage I to III Non-Small-Cell Lung Cancer With Limited Evidence 
  American Thoracic Society, 2013 International Conference, Philadelphia, Pennsylvania, USA
• Join now to see all